Veraxa Biotech Holding AG (VRXA) Total Liabilities (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Total Liabilities for 2 consecutive years, with $120.8 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 97.1% year-over-year to $120.8 million; the trailing twelve-month figure through Dec 2025 stood at $120.8 million (up 97.1% YoY), and the FY2025 full-year result was $120.8 million, up 97.1% from the prior year.
• Total Liabilities grew to $120.8 million in Q4 2025 per VRXA's latest filing, from $61.3 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $120.8 million in Q4 2025 to a low of $61.3 million in Q4 2024.